Tianjin Medical Journal ›› 2020, Vol. 48 ›› Issue (4): 343-347.doi: 10.11958/20192717

• Review • Previous Articles     Next Articles

Research progress of STAT3 signaling pathway in insulin resistance #br#

LIU Hong-fei, WEI Cui-ying△ #br#   

  1. The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology,
    Baotou 014010, China

  • Received:2019-09-02 Revised:2019-12-21 Published:2020-04-15 Online:2020-06-23
  • Contact: WEI Cui-ying E-mail:weicuiying9@163.com
  • Supported by:

Abstract: Insulin resistance (IR) is an important mechanism of type 2 diabetes. It affects the transmission of various
signaling pathways, thereby disrupting glucose metabolism. Signaling and the transcriptional activation factor 3 (STAT3)
pathway are important pathways that regulate gene transcription. There is evidence that STAT3 signaling pathway is a key
factor of IR, which can regulate the mitogen-activated protein kinase (MAPK) pathway, insulin receptor substrate-1 (IRS-1) /phosphatidyl inositol 3 kinase (P13K) / protein kinase B (PKB) pathway and other insulin-related pathways. The STAT3
signaling pathway is activated by the upstream cytokine interleukin-22 (IL-22) and is involved in the regulation of glucose
metabolism. It is a current research hotspot. This article reviews the relationship between the STAT3 pathway and IR to
further clarify the pathogenesis of glucose metabolism.

Key words: diabetes mellitus, type 2, STAT3 signaling pathway, insulin resistance

CLC Number: